Adcentrx Therapeutics
PrivateLast Round
Series A
Extension
Dec 5, 2023
Total Funding Raised
$114M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Adcentrx Therapeutics is a biotechnology company that develops protein conjugate therapeutics for the treatment of cancer and other life-threatening diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adcentrx Therapeutics Comparables
Compare Adcentrx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Solve Therapeutics | 90% | |
| Kivu Biosciences | 90% | |
| MBrace Therapeutics | 89% |
Adcentrx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 5, 2023 | ||||
| Series A Extension | Apr 24, 2023 | ||||
| Series A | Apr 28, 2021 |
Adcentrx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abio-X | Series A Extension |
| Boyu Capital | Series A |
| Zoo Capital | Series A |
| F-Prime Capital | Series A Extension |
| Eight Roads Ventures | Series A Extension |
| CBC Group | Series A |
| Trinity Innovation Fund | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 38% MoM.
- Apr 23, 2025
Will present at the 2025 ASCO Annual Meeting in Chicago.
Adcentrx Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Adcentrx Therapeutics's valuation, stock price, and market status.
Is Adcentrx Therapeutics a public or private company?
Adcentrx Therapeutics is a private company.
What is the current stock price of Adcentrx Therapeutics?
Adcentrx Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Adcentrx Therapeutics worth (valuation)?
Valuation information for Adcentrx Therapeutics is not publicly available.
Can I buy Adcentrx Therapeutics stock?
Adcentrx Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Adcentrx Therapeutics's last funding round?
Adcentrx Therapeutics's most recent funding round was Series A Extension on December 5, 2023.
Who are the main investors in Adcentrx Therapeutics?
Key investors in Adcentrx Therapeutics include Eight Roads Ventures, CBC Group.
Will Adcentrx Therapeutics IPO soon?
No public IPO plans have been announced for Adcentrx Therapeutics.
How can I track Adcentrx Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Adcentrx Therapeutics's secondary market activity and sign up for updates.